Weifeng Luo

1.2k total citations
43 papers, 905 citations indexed

About

Weifeng Luo is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Weifeng Luo has authored 43 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in Weifeng Luo's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (12 papers) and Neurological disorders and treatments (9 papers). Weifeng Luo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Botulinum Toxin and Related Neurological Disorders (12 papers) and Neurological disorders and treatments (9 papers). Weifeng Luo collaborates with scholars based in China, United States and United Kingdom. Weifeng Luo's co-authors include Chun‐Feng Liu, Tong Liu, Qilin Zhang, Guodong Xiao, Li‐Fang Hu, Chengjie Mao, Tingting Huang, Xingshun Xu, Yaping Yang and Ya Huang and has published in prestigious journals such as PLoS ONE, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

Weifeng Luo

42 papers receiving 896 citations

Peers

Weifeng Luo
Wooyoung Jang South Korea
Won‐Ha Lee South Korea
Nurgül Aytan United States
Yunqi Xu China
Maurizio Facheris United States
Li Gong China
Wooyoung Jang South Korea
Weifeng Luo
Citations per year, relative to Weifeng Luo Weifeng Luo (= 1×) peers Wooyoung Jang

Countries citing papers authored by Weifeng Luo

Since Specialization
Citations

This map shows the geographic impact of Weifeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifeng Luo more than expected).

Fields of papers citing papers by Weifeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weifeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifeng Luo. The network helps show where Weifeng Luo may publish in the future.

Co-authorship network of co-authors of Weifeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Weifeng Luo. A scholar is included among the top collaborators of Weifeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weifeng Luo. Weifeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wan, Ying, Rong Lu, Suzhi Liu, et al.. (2025). Integrative Approaches Identify Genetic Determinants of Levodopa Induced Dyskinesia. Molecular Neurobiology. 62(9). 11572–11580. 1 indexed citations
2.
Xiao, Guodong, Chunmei Wu, Lijuan Huang, et al.. (2024). The protective effects of repetitive transcranial magnetic stimulation with different high frequencies on motor functions in MPTP/probenecid induced Parkinsonism mouse models. Brain and Behavior. 14(7). e3605–e3605. 3 indexed citations
3.
Shi, Xin, Xiaozhong Zhou, Gang Chen, et al.. (2024). Targeting the postsynaptic scaffolding protein PSD-95 enhances BDNF signaling to mitigate depression-like behaviors in mice. Science Signaling. 17(834). eadn4556–eadn4556. 19 indexed citations
4.
Shen, Tingting, Yang Li, Yingying Xu, et al.. (2024). Association analyses between the variants of SNAP25, SV2C and ST3GAL2 and the efficacy of botulinum toxin A in the treatment of the primary Meige syndrome. Heliyon. 10(8). e28543–e28543. 1 indexed citations
6.
Yang, Li, Jing Liu, Xu Liu, et al.. (2019). Antidepressant-Like Action of Single Facial Injection of Botulinum Neurotoxin A is Associated with Augmented 5-HT Levels and BDNF/ERK/CREB Pathways in Mouse Brain. Neuroscience Bulletin. 35(4). 661–672. 39 indexed citations
8.
Wang, Bing, Cunjin Su, Tengteng Liu, et al.. (2018). The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson’s Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy. Frontiers in Molecular Neuroscience. 11. 120–120. 46 indexed citations
9.
Yun, Wenwei, et al.. (2018). Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson’s disease or essential tremor. Journal of International Medical Research. 46(4). 1477–1485. 31 indexed citations
10.
Si, Meng, Ya Huang, Lihua Chen, et al.. (2017). Long-term anti-itch effect of botulinum neurotoxin A is associated with downregulation of TRPV1 and TRPA1 in the dorsal root ganglia in mice. Neuroreport. 28(9). 518–526. 19 indexed citations
11.
Sheng, Yulan, Xing Chen, Xiao‐Ou Hou, et al.. (2017). Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy. Experimental Neurology. 297. 138–147. 30 indexed citations
12.
Zhang, Yingchun, Xiaofang Chen, Qi Ma, et al.. (2016). Sonographic Alteration of Basal Ganglia in Different Forms of Primary Focal Dystonia. Chinese Medical Journal. 129(8). 942–945. 6 indexed citations
13.
Xiao, Guodong, et al.. (2016). Minocycline Suppresses NLRP3 Inflammasome Activation in Experimental Ischemic Stroke. NeuroImmunoModulation. 23(4). 230–238. 71 indexed citations
14.
Wang, Linlin, Xingyue Hu, Hongjuan Dong, et al.. (2014). Clinical features and treatment status of hemifacial spasm in China. Chinese Medical Journal. 127(5). 845–849. 24 indexed citations
15.
Zhang, Ning, Qilin Zhang, & Weifeng Luo. (2014). Molecular mechanism of protection of uric acid on dopaminergic neurons. Chinese Journal of Neuromedicine. 13(6). 635–638. 1 indexed citations
16.
Zhang, Ning, Tingting Huang, Qilin Zhang, et al.. (2014). Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity. PLoS ONE. 9(6). e100286–e100286. 55 indexed citations
17.
Wang, Xiaoxia, Weifeng Luo, Qilin Zhang, et al.. (2011). Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action. Neuroscience Letters. 506(2). 175–179. 47 indexed citations
18.
Zhu, Hongdong, et al.. (2008). Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels. Neuroscience. 157(4). 884–894. 20 indexed citations
19.
Luo, Weifeng. (2003). Effects of medications on dopamine of rat corpus striatum treated with 6-OHDA. 1 indexed citations
20.
Kataoka, Kiyoshi, Tetsuo Satoh, Ken Sasaki, et al.. (1998). Effect of Rat Glicentin on Intestinal Adaptation in Small Intestine‐Resected Rats. Annals of the New York Academy of Sciences. 865(1). 601–605. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026